-->

Tag: Peptide receptor radionuclide therapy

Home / Peptide receptor radionuclide therapy

Categories

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients 12 years and older with GEP-NETS

Lutetium Lu 177 dotatate is approved by USFDA for pediatric patients The Food and Drug Administration has approved lutetium Lu 177 dotatate (Lutathera, Advanced Accelerator Applications USA, Inc., a ...
peptide-receptor-radionuclide-therapy

pancreatic neuroendocrine tumors peptide receptor radionuclide therapy (PRRT)


peptide-receptor-radionuclide-therapy

pheochromocytoma peptide receptor radionuclide therapy (PPRT)


peptide-receptor-radionuclide-therapy

Scan the code